Full metadata record
DC FieldValueLanguage
dc.creatorFotopoulou, C. (C.)-
dc.creatorSehouli, J. (J.)-
dc.creatorMahner, S. (S.)-
dc.creatorHarter, P. (P.)-
dc.creatorVan-Nieuwenhuysen, E. (E.)-
dc.creatorGonzález-Martín, A. (Antonio)-
dc.creatorVergote, I. (I.)-
dc.creatorChiva, I. (I.)-
dc.creatorDu-Bois, A. (A.)-
dc.date.accessioned2023-03-16T08:43:19Z-
dc.date.available2023-03-16T08:43:19Z-
dc.date.issued2018-
dc.identifier.citationFotopoulou, C. (C.); Sehouli, J. (J.); Mahner, S. (S.); et al. "HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?". Annals of oncology. 29 (8), 2018, 1610 - 1613es
dc.identifier.issn0923-7534-
dc.identifier.urihttps://hdl.handle.net/10171/65693-
dc.description.abstractUndergoing an era of revolutionary new knowledge and advances in the systemic and surgical treatment of peritoneally disseminated epithelial ovarian cancer (EOC), we never before have been confronted with such a plethora of novel targeted agents, genetically based treatment strategies and cutting edge surgical techniques that enrich our armamentarium in the fight against this deadly disease [1–3]. Still, our art as clinicians is to put all this new body of knowledge into the right context so that we can help our patients without compromising their care through an enthusiastic effort of implementing new therapeutices_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectRevolutionary new knowledgees_ES
dc.subjectSystemic and surgical treatmentes_ES
dc.titleHIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doi10.1093/annonc/mdy198-
dadun.citation.endingPage1613es_ES
dadun.citation.number8es_ES
dadun.citation.publicationNameAnnals of oncologyes_ES
dadun.citation.startingPage1610es_ES
dadun.citation.volume29es_ES

Files in This Item:
Thumbnail
File
1-s2.0-S0923753419341195-main.pdf
Description
Size
125.71 kB
Format
Adobe PDF


Statistics and impact

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.